Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity
Authors:
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 320, 32-44
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81603035, 2018T110986, 81873662, 81870599)
This publication has 45 references indexed in Scilit:
- Targeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamineJournal of Controlled Release, 2013
- Characterization of CD44-Mediated Cancer Cell Uptake and Intracellular Distribution of Hyaluronan-Grafted LiposomesMolecular Pharmaceutics, 2011
- Targeting kidney mesangium by nanoparticles of defined sizeProceedings of the National Academy of Sciences, 2011
- Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells☆Advanced Drug Delivery Reviews, 2010
- Renal fibrosis: novel insights into mechanisms and therapeutic targetsNature Reviews Nephrology, 2010
- Endocytosis of nanomedicinesJournal of Controlled Release, 2010
- The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agentsBiomaterials, 2010
- Biomimetic amplification of nanoparticle homing to tumorsProceedings of the National Academy of Sciences, 2007
- Renal fibrosis: New insights into the pathogenesis and therapeuticsKidney International, 2006
- Serum Enzyme Determinations in the Diagnosis and Assessment of Myocardial InfarctionCirculation, 1972